SYROS PHARMACEUTICALS, INC. Restructuring Charges
SYROS PHARMACEUTICALS, INC. reported Restructuring Charges of $2.49 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2024-10-31
- SYROS PHARMACEUTICALS, INC. restructuring charges for the quarter ending 2023-12-31 was $135.00K.
- SYROS PHARMACEUTICALS, INC. restructuring charges for the quarter ending 2023-09-30 was $2.35M.
- SYROS PHARMACEUTICALS, INC. restructuring charges for fiscal 2023 was $2.49M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2023-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.49M derived: sum of 2 quarters · filed 2024-10-31 | $2.49M 10-K · filed 2024-03-27 | |
| 2023-09-30 | $2.35M 10-Q · filed 2024-10-31 | $2.35M 10-Q · filed 2024-10-31 |